Cofactors that may influence vaccine responses
- 1 September 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in HIV and AIDS
- Vol. 5 (5), 404-408
- https://doi.org/10.1097/coh.0b013e32833d1fca
Abstract
Purpose of review This review summarizes recent developments related to cofactors that may influence response to vaccination. Recent findings The unexpected increased HIV acquisition among vaccinees in the Step trial with prior exposure to adenovirus type 5 (Ad5) led to several studies trying to understand whether an underlying biological risk factor may have been responsible for this observation. Demographic factors and genetic background of the human populations in HIV vaccine trials remain a source of potential variation in responses observed in vaccine trials, yet empirical data remain limited on the impact of those factors. Coinfections, particularly those that may modulate the immune response, are a further concern for HIV vaccine trialists, with recent data providing further insight into effects of coinfections on innate and adaptive immunity and vaccine responses. Summary Individuals and human populations display variation in response to vaccination. Key explanatory variables for this variation include host factors, such as host genetics, and environmental factors, such as prior exposure to the vaccine vector, coinfection with other pathogens, and demographic factors. This review will outline some of the recent developments investigating the role of various cofactors on vaccine responses, with a particular emphasis on studies of HIV vaccines.Keywords
This publication has 62 references indexed in Scilit:
- Host Determinants of HIV‐1 Control in African AmericansThe Journal of Infectious Diseases, 2010
- Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individualsAIDS, 2010
- Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10Vaccine, 2010
- Helminth Cysteine Proteases Inhibit TRIF-dependent Activation of Macrophages via Degradation of TLR3Online Journal of Public Health Informatics, 2010
- Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cellsNature Medicine, 2009
- Post-Step modifications for research on HIV vaccinesAIDS, 2009
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisThe Lancet, 2008
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cellsThe Journal of Experimental Medicine, 2008
- Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesAIDS, 2008